These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 17686264

  • 1. [Difference in examination of coagulation function in heparin anticoagulant therapy between point of care tests and automatic coagulation analyzer].
    Li J, Cong YL, Tu GH, Yang L, Zhu BB, Jin L.
    Zhonghua Yi Xue Za Zhi; 2007 May 15; 87(18):1269-71. PubMed ID: 17686264
    [Abstract] [Full Text] [Related]

  • 2. Standardization of coagulation tests.
    Opartkiattikul N.
    Southeast Asian J Trop Med Public Health; 1999 May 15; 30 Suppl 3():79-85. PubMed ID: 10926265
    [Abstract] [Full Text] [Related]

  • 3. Comparability of the results of PT-INR with local MNPT and APTTR with MNAPTT on different coagulation analyzers in China.
    Peng L, Yan C, Wu X, Nie L.
    Int J Lab Hematol; 2009 Jun 15; 31(3):352-8. PubMed ID: 18510575
    [Abstract] [Full Text] [Related]

  • 4. Clinical evaluation of a microsample coagulation analyzer, and comparison with existing techniques.
    Carter AJ, Hicks K, Heldman AW, Resar JR, Laird JR, Coombs VJ, Brinker JA, Blumenthal RS.
    Cathet Cardiovasc Diagn; 1996 Sep 15; 39(1):97-102. PubMed ID: 8874958
    [Abstract] [Full Text] [Related]

  • 5. Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy.
    Jonsson M, Hillarp A, Svensson P.
    Thromb Res; 2004 Sep 15; 114(2):83-9. PubMed ID: 15306149
    [Abstract] [Full Text] [Related]

  • 6. Use of EDTA samples for prothrombin time measurement in patients receiving oral anticoagulants.
    Horsti J.
    Haematologica; 2001 Aug 15; 86(8):851-5. PubMed ID: 11522542
    [Abstract] [Full Text] [Related]

  • 7. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
    Testa S, Morstabilini G, Fattorini A, Galli L, Denti N, D'Angelo A.
    Haematologica; 2002 Dec 15; 87(12):1265-73. PubMed ID: 12495900
    [Abstract] [Full Text] [Related]

  • 8. Association between prothrombin activation fragment (F1.2), cerebral ischemia (S-100beta) and international normalized ratio (INR) in patients with ventricular assisted devices.
    Joshi A, Magder LS, Kon Z, Kallam S, Kwon M, Sangrampurkar R, Pierson R, Poston R.
    Interact Cardiovasc Thorac Surg; 2007 Jun 15; 6(3):323-7. PubMed ID: 17669856
    [Abstract] [Full Text] [Related]

  • 9. Comparison of three prothrombin time and activated partial thromboplastin time reagent systems on the MLA 700 coagulation analyzer.
    Kritikos VG, Melhem MF.
    Clin Lab Sci; 1993 Jun 15; 6(5):302-7. PubMed ID: 10146556
    [Abstract] [Full Text] [Related]

  • 10. A new plastic collection tube made of polyethylene terephtalate is suitable for monitoring traditional anticoagulant therapy (oral anticoagulant, unfractionated heparin, and low molecular weight heparin).
    Toulon P, Ajzenberg N, Smahi M, Guillin MC.
    Thromb Res; 2007 Jun 15; 119(2):135-43. PubMed ID: 16426667
    [Abstract] [Full Text] [Related]

  • 11. [Impact of heparin on coagulation index during the therapy of molecular adsorbent recirculating system in patients with liver failure].
    Yuan S, Zhou Y, Tan D, Li D, Zhou T, Xie Q, Fan J.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Sep 15; 36(9):830-5. PubMed ID: 21946197
    [Abstract] [Full Text] [Related]

  • 12. Oral anticoagulant therapy and international normalized ratios in swine.
    McGlasson DL, Brickey DA, Doe RH.
    Lab Anim Sci; 1998 Aug 15; 48(4):371-3. PubMed ID: 10090045
    [Abstract] [Full Text] [Related]

  • 13. The monitoring of heparin administration by screening tests in experimental dogs.
    Mischke R, Jacobs C.
    Res Vet Sci; 2001 Apr 15; 70(2):101-8. PubMed ID: 11356088
    [Abstract] [Full Text] [Related]

  • 14. Validation of a bedside activated clotting time test (Hemochron Jr II Signature) with low dose heparin therapy.
    Racioppi L, Quinart A, Biais M, Nouette-Gaulain K, Revel P, Sztark F.
    Anaesthesia; 2009 Apr 15; 64(4):430-4. PubMed ID: 19317710
    [Abstract] [Full Text] [Related]

  • 15. Point-of-care coagulation testing for assessment of the pharmacodynamic anticoagulant effect of direct oral anticoagulant.
    Mani H, Herth N, Kasper A, Wendt T, Schuettfort G, Weil Y, Pfeilschifter W, Linnemann B, Herrmann E, Lindhoff-Last E.
    Ther Drug Monit; 2014 Oct 15; 36(5):624-31. PubMed ID: 24577124
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT, Monn A, Tavakoli R, Genoni M, Klaghofer R, Furrer L, Honegger H, Hofer CK.
    Eur J Cardiothorac Surg; 2006 Aug 15; 30(2):278-84. PubMed ID: 16828293
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Discard volumes necessary for clinically useful coagulation studies from heparinized Hickman catheters.
    Mayo DJ, Dimond EP, Kramer W, Horne MK.
    Oncol Nurs Forum; 1996 May 15; 23(4):671-5. PubMed ID: 8735325
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.